425 related articles for article (PubMed ID: 25500239)
1. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
Rosenson RS; Davidson MH; Hirsh BJ; Kathiresan S; Gaudet D
J Am Coll Cardiol; 2014 Dec; 64(23):2525-40. PubMed ID: 25500239
[TBL] [Abstract][Full Text] [Related]
2. Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.
Shaik A; Rosenson RS
Cardiovasc Drugs Ther; 2021 Jun; 35(3):677-690. PubMed ID: 33710501
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
4. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
Hussain A; Ballantyne CM; Saeed A; Virani SS
Curr Atheroscler Rep; 2020 Jun; 22(7):25. PubMed ID: 32494924
[TBL] [Abstract][Full Text] [Related]
5. The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.
Borén J; Packard CJ; Taskinen MR
Front Endocrinol (Lausanne); 2020; 11():474. PubMed ID: 32849270
[TBL] [Abstract][Full Text] [Related]
6. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
Sandesara PB; Virani SS; Fazio S; Shapiro MD
Endocr Rev; 2019 Apr; 40(2):537-557. PubMed ID: 30312399
[TBL] [Abstract][Full Text] [Related]
7. New Therapies for Lowering Triglyceride-Rich Lipoproteins: JACC Focus Seminar 3/4.
Rosenson RS; Shaik A; Song W
J Am Coll Cardiol; 2021 Nov; 78(18):1817-1830. PubMed ID: 34711341
[TBL] [Abstract][Full Text] [Related]
8. Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review.
Plaisance EP; Grandjean PW; Mahurin AJ
Phys Sportsmed; 2009 Apr; 37(1):11-9. PubMed ID: 20048483
[TBL] [Abstract][Full Text] [Related]
9. Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model.
Funatsu T; Kakuta H; Takasu T; Noguchi M; Suzuki M; Miyata K
Metabolism; 2003 May; 52(5):609-15. PubMed ID: 12759892
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies.
Norata GD; Grigore L; Raselli S; Seccomandi PM; Hamsten A; Maggi FM; Eriksson P; Catapano AL
J Mol Cell Cardiol; 2006 Apr; 40(4):484-94. PubMed ID: 16516917
[TBL] [Abstract][Full Text] [Related]
11. Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis.
Schwartz EA; Reaven PD
Biochim Biophys Acta; 2012 May; 1821(5):858-66. PubMed ID: 22001233
[TBL] [Abstract][Full Text] [Related]
12. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
Chapman MJ
Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
[TBL] [Abstract][Full Text] [Related]
13. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.
Quispe R; Alfaddagh A; Kazzi B; Zghyer F; Marvel FA; Blumenthal RS; Sharma G; Martin SS
Curr Atheroscler Rep; 2022 Jul; 24(7):571-581. PubMed ID: 35499805
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypertriglyceridemia with omega-3 fatty acids].
Miyoshi T; Ito H
Nihon Rinsho; 2013 Sep; 71(9):1650-4. PubMed ID: 24205729
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia.
Moon JH; Kim K; Choi SH
Endocrinol Metab (Seoul); 2022 Aug; 37(4):575-586. PubMed ID: 36065644
[TBL] [Abstract][Full Text] [Related]
16. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
17. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
Foley EM; Esko JD
Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.
Duran EK; Pradhan AD
Clin Chem; 2021 Jan; 67(1):183-196. PubMed ID: 33409533
[TBL] [Abstract][Full Text] [Related]
19. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.
Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL
Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253
[TBL] [Abstract][Full Text] [Related]
20. Triglycerides and endothelial function: molecular biology to clinical perspective.
Kajikawa M; Higashi Y
Curr Opin Lipidol; 2019 Oct; 30(5):364-369. PubMed ID: 31348023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
